Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

MHRA issues defect alert for ADHD drug Xaggitin XL

The Medicines and Healthcare Products Regulatory Agency (MHRA) has issued a Class 4 medicines defect notification for Xaggitin XL Prolonged-release tablets.

NHS Bedfordshire and Luton CYP services
Lupin spins out two cancer drug programmes to Kaveri Therapeutics

The three-year Neighbourhood Early Diagnosis Fund totalling £200 million will enable Cancer Alliances to support their local NHS to reduce inequalities in communities.

iStock
Health sector leaders welcome appointment of Yvette Cooper

The pharmacy and medical industry leaders hope to work with the new health secretary.

Reuters